Clozapine is an effective anti-psychotic and has long been used as an intervention for treatment-resistant schizophrenia. This case report will highlight the use of Clozapine up to 100 mg ON as a second-line medication to achieve satisfactory response after 5 weeks in an adolescent who was recently diagnosed with schizophrenia.
Introduction: Alcohol is a major risk factor for various non-communicable diseases (NCDs) such as cardiovascular related illnesses, liver cirrhosis and cancer. Despite the dangers of alcohol use, there is limited local research available to assist policy and advocacy. This commentary attempts to highlight what is presently available and suggestions to move forward in this field of research and services provision. Methods: A brief report of recent updates is provided for this article. Results and Conclusion: A number of recommendations are provided to assist in deliberating discussions to shape future policies which will improve current available practice and clinical service in the field of alcohol addiction.